Neuroplastic Changes Seen in Cochlear Implants With Preserved Hearing

Sponsor
Manchester University NHS Foundation Trust (Other)
Overall Status
Withdrawn
CT.gov ID
NCT02407587
Collaborator
(none)
0
1
2
45.9
0

Study Details

Study Description

Brief Summary

Investigators hope to study patients with 1 cochlear implant and who have had hearing preservation surgery and compare the changes in the brain of these patients with normal hearing patients by doing a scan of the brain when listening to speech. The information investigators collect may help investigators to understand how the brain learns to hear with a cochlear implant and whether it uses the same areas in the brain to listen as in normal hearing patients as well as predict which patients will do well with a cochlear implant as a very specialised operation is needed to insert the cochlear implant in to the ear and is done by very few surgeons in the country. After the operation, patients need several months of teaching to help them learn how to hear through the implant. Having a cochlear implant requires a lot of cooperation and time from the patient and if investigators could understand how the brain learns to hear with a cochlear implant and predict which patients do well and why then we may be able to avoid unnecessary procedures.

Condition or Disease Intervention/Treatment Phase
  • Device: cochlear implants
N/A

Detailed Description

Cochlear implants are an established treatment for individuals with hearing loss where conventional hearing aids fail to provide appropriate hearing amplification and result in poor speech and language perception.

Although a large proportion of patients with cochlear implants are expected to do well with an implant, there is still uncertainty why some individuals do poorly.

Furthermore investigators have limited knowledge about how the brain interacts with a cochlear implant to process speech. Evidence suggests that the underlying central mechanisms responsible for processing speech using an implant are related to neuroplasticity. That is to say that the brain establishes new cortical networks between the vital auditory centres and the cochlear implant thus enabling processing of speech.

Investigators have recently completed a study comparing the cortical changes that occur in subjects with bilateral cochlear implants to normal hearing controls. In this study both groups of patients were subjected to binaural simultaneous auditory stimuli. Analysis suggests that subjects with bilateral cochlear implants and postlingual hearing loss seem to recruit similar areas of the temporal lobes to process speech as their normal hearing counterparts.

The implant recipients activations were larger and more diffuse but did not differ greatly from those described previously in normal hearing. This study provides a good comparison of hearing using bilateral cochlear implants to that of normal unaided hearing. This study provides a more realistic comparison of cortical activations due to hearing in cochlear implantees and normal hearing subjects. This is in contrast to other studies involving monaural stimulation of a unilateral cochlear implant to monaural stimulation of normal hearing subject with the contralateral normal hearing ear blocked off. Investigators are only aware of one additional study where subjects with bilateral cochlear implants have been compared to normal hearing controls.

In addition investigators did not observe any recruitment of the visual cortices in our bilaterally implanted subjects. This finding was also present in Strelnikov's study. However previous work has suggested subjects with cochlear implants rely on visual clues to process speech as a result of the degraded signal provided by the implant. It is possible that because the subjects in this study and Strelnikov's study were experienced implant users and benefited from binaural auditory stimulation, they were not dependant on audio-visual integration to process speech.

There has been an increasing trend towards hearing preservation surgery for patients undergoing cochlear implantation. Literature supports improved speech and pitch perception in quiet and noise for subjects who combine the use of their implant with any residual preserved natural hearing compared with using the implant alone. Once again the the underlying mechanisms for this are unknown. It would be of scientific interest to investigate the interaction between natural residual hearing and hearing via a cochlear implant. It is likely that this cohort of subjects process speech similarly to those with normal hearing.

Finally, studies have monitored the speech progression of implantees from before surgery to several years post implant switch on. It has been suggested that the predominant improvement in speech perception occurs in the first year of implant use. This would suggest that the neuronal networks responsible for speech processing are established very early on however, investigators are not aware of any studies which have attempted to track the evolution of the temporal cortices in new recipients of cochlear implants.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Cortical Activity in Subjects With Unilateral Cochlear Implants and Preserved Ipsilateral Residual Hearing and the Evolution of Temporal Cortex Changes in New Recipients of Cochlear Implants.
Anticipated Study Start Date :
May 1, 2013
Anticipated Primary Completion Date :
Oct 1, 2015
Actual Study Completion Date :
Feb 27, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: unilateral cochlear implants

Study Group PET scans for the mature patients with unilateral cochlear implants and preserved hearing 4 states and each state will be repeated 3 times Cochlear implant only Residual hearing only Combination of implant and residual hearing No auditory stimulation

Device: cochlear implants
PET scans for the mature patients with unilateral cochlear implants and preserved hearing 4 states and each state will be repeated 3 times Cochlear implant only Residual hearing only Combination of implant and residual hearing No auditory stimulation

No Intervention: Healthy volunteers

4 states and each state will be repeated 3 times Auditory stimulation Left ear only Auditory stimulation right ear only Binaural auditory stimulation Silence

Outcome Measures

Primary Outcome Measures

  1. Increase our understanding of why outcomes following a cochlear implant are heterogenous. This information may be used to provide targeted rehabilitation for candidates performing poorly with their implants and minimise rejection of the implant. [1 year]

    We anticipate that the recruitment of patients, data collection and analysis would take a maximum of 4 months Study Group PET scans for the mature patients with unilateral cochlear implants and preserved hearing 4 states and each state will be repeated 3 times Cochlear implant only Residual hearing only Combination of implant and residual hearing No auditory stimulation Control Group 4 states and each state will be repeated 3 times Auditory stimulation Left ear only Auditory stimulation right ear only Binaural auditory stimulation Silence

Secondary Outcome Measures

  1. Combine the data from both of our studies and future studies in order to conduct meta-analysis to investigate further how language is processed in patients with cochlear implants. [1 year]

  2. Determine if functional neuroimaging modalities have a future role in the selection process for potential cochlear implant candidates and in predicting outcome for each individual. [1 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Mature users of unilateral cochlear implants who have natural preserved hearing in the implanted ear

  • Healthy volunteers with normal hearing

  • Right handed

Exclusion Criteria:
  • Individuals with neurological or psychiatric illness

  • Patients involved in additional drug trials

  • Pregnant or breast feeding women

  • Children

  • Left-handed subjects

Contacts and Locations

Locations

Site City State Country Postal Code
1 Central Manchester University Hospitals NHS Foundation Trust Manchester Manchester (Manchester Borough) United Kingdom M13 9WL

Sponsors and Collaborators

  • Manchester University NHS Foundation Trust

Investigators

  • Principal Investigator: Rohini Aggrawal, Manchester University NHS Foundation Trust

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Manchester University NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT02407587
Other Study ID Numbers:
  • R01997
First Posted:
Apr 3, 2015
Last Update Posted:
Jan 18, 2019
Last Verified:
Jan 1, 2019
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 18, 2019